ERNA Ernexa Therapeutics CEO corner highlights differentiated erna-101 platform as company advances toward planned first-in-human phase 1 st

ERNA Ernexa Therapeutics CEO corner highlights differentiated erna-101 platform as company advances toward planned first-in-human phase 1 study in 2026